We could be creating a food allergy epidemic because we are not weaning babies on to allergens sooner, according to a leading paediatric allergy specialist.
Public Health England’s advice urges the introduction of peanuts and other allergens from around six months but Gideon Lack, professor of paediatric allergy at King’s College London, said that could be two months too late.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology company focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.